Linus Biotechnology
LinusBio is a pioneering platform company developing precision exposome biomarkers from hair analysis for earlier diagnoses, enhanced patient monitoring, and accelerated drug development. Their proprietary technology utilizes robotics, laser systems, and mass spectrometry, analyzed by an AI pipeline, to identify molecular signatures from hair strands. This allows for mapping human physiology over time, providing a single assay with the information equivalent to hundreds of blood tests. Their product, ClearStrand-ASD, is a non-invasive diagnostic aid for Autism Spectrum Disorder. LinusBio is also developing tests for CNS disorders like ALS, ADHD, and Schizophrenia, aiming to replace subjective assessments with objective, data-driven insights to transform healthcare.
Linus Biotechnology
LinusBio is a pioneering platform company developing precision exposome biomarkers from hair analysis for earlier diagnoses, enhanced patient monitoring, and accelerated drug development. Their proprietary technology utilizes robotics, laser systems, and mass spectrometry, analyzed by an AI pipeline, to identify molecular signatures from hair strands. This allows for mapping human physiology over time, providing a single assay with the information equivalent to hundreds of blood tests. Their product, ClearStrand-ASD, is a non-invasive diagnostic aid for Autism Spectrum Disorder. LinusBio is also developing tests for CNS disorders like ALS, ADHD, and Schizophrenia, aiming to replace subjective assessments with objective, data-driven insights to transform healthcare.